News

Candel Therapeutics essentially uses a dual-virus strategy with CAN-2409 and CAN-3110 immunotherapies. Find out why CADL ...
A shocking new study out of Norway has revealed a popular class of medications can make it easier to catch Covid and the flu.
Broad Institute researchers have developed a way to edit the genetic sequences at the root of Huntington's disease and ...
The FDA ordered a clinical hold on Rocket Pharmaceuticals' Danon disease trial after the adverse event was first disclosed.
Researchers have developed a new viral delivery system designed efficiently to target the lungs and respiratory airways. It could help in tackling various respiratory illnesses including pulmonary fib ...
While India grapples with rising Covid cases and prepares for potential biological threats, the government's neglect of its ...
India is experiencing a surge in Covid-19 cases, primarily driven by the JN.1 Omicron sub-variant, prompting increased ...
Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.
A new nasal spray-based gene therapy, using AAV.CPP.16 shows promise for treating lung diseases like COVID-19 and pulmonary ...